PhRMA federal legislation division
Michael Reed, previously VP-government relations, to newly created post of senior legislative counsel in a reorganization of the federal legislation division announced May 9 by newly hired Executive VP-Strategic and Legislative Affairs Stephen Conafay. Deputy VP-Government Relations Lynda Nersesian will retain her title, as will legislative counsels Albert Saunders and Jeffrey Anders. Reed and Nersesian both will report to Conafay. Lara Robillaird -- formerly with Jones, Day, Reavis and Pogue, where Conafay held an of-counsel position before coming to PhRMA -- will join PhRMA as federal legislation associate. In announcing the changes, Conafay declares his intention to take an active, personal role in lobbying: "Mike Reed is one of the most respected and best-liked members of the legislative community, but I want to be directly involved in the daily federal legislative decisions and activities of PhRMA
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth